Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene

A P Levy1

  • 1Technion Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Acta Diabetologica
|January 6, 2004
PubMed

Insights

Genetic factors influence coronary artery disease risk in diabetics. The haptoglobin gene locus is a key susceptibility factor for diabetic vascular complications, beyond traditional risk factors.

Area of Science:

  • Cardiovascular Genetics
  • Diabetology
  • Molecular Medicine

Background:

  • Diabetic patients exhibit varied susceptibility to coronary artery disease (CAD).
  • Conventional cardiac risk factors and diabetes control do not fully explain this differential susceptibility.
  • Genetic predisposition is increasingly recognized as a factor in diabetic vascular complications.

Purpose of the Study:

  • To review the role of genetic susceptibility factors in diabetic CAD.
  • To highlight the haptoglobin locus as a specific genetic factor in diabetic vascular complications.

Main Methods:

  • Literature review focusing on genetic associations with diabetic cardiovascular disease.
  • Analysis of studies investigating the haptoglobin locus and its relation to diabetic complications.

Main Results:

  • The haptoglobin (HP) locus is identified as a significant genetic susceptibility factor.
  • HP variations may contribute to the development of vascular complications in diabetic individuals.
  • This genetic influence operates independently of established risk factors.

Conclusions:

  • Genetic factors, particularly at the haptoglobin locus, play a crucial role in diabetic CAD.
  • Understanding these genetic elements is vital for personalized risk assessment and treatment strategies in diabetes.
  • Further research into the haptoglobin locus can elucidate mechanisms of diabetic vascular disease.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...